* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download as a PDF
Gene expression wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Biochemical cascade wikipedia , lookup
Magnesium transporter wikipedia , lookup
Expression vector wikipedia , lookup
Ribosomally synthesized and post-translationally modified peptides wikipedia , lookup
Point mutation wikipedia , lookup
Metalloprotein wikipedia , lookup
Ancestral sequence reconstruction wikipedia , lookup
Signal transduction wikipedia , lookup
Interactome wikipedia , lookup
G protein–coupled receptor wikipedia , lookup
Lipid signaling wikipedia , lookup
Western blot wikipedia , lookup
Ultrasensitivity wikipedia , lookup
Protein structure prediction wikipedia , lookup
Paracrine signalling wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Protein–protein interaction wikipedia , lookup
Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup
Protein purification wikipedia , lookup
Proteolysis wikipedia , lookup
Journal of Neurochemistry Raven Press, Ltd., New York C 1994 International Society for Neurochemistry Protein Kinase FA/Glycogen Synthase Kinase-3a After Heparin Potentiation Phosphorylates Ton Sites Abnormally Phosphorylated in Alzheimer's Disease Brain Shiaw-Der Yang, Jau-Song Yu, Shine-Gwo Shiah, and Jun-Jae Huang Institute of Biomedical Sciences, National Tsing Hua University, Hsinchu, and Institute of Basic Medicine, Chang Gung Medical College, Tao-Yuan, Taiwan, R .O.C. Abstract : Previously, we identified protein kinase FA/glycogen synthase kinase-3a (GSK-3a) as a brain microtubule-associated T kinase that phosphorylates Ser 235 and Ser' o4 of T and causes its electrophoretic mobility shift in gels, a unique property characteristic of paired helical filament-associated pathological T (PHF-T) in Alzheimer's disease brains . In this study, we found that the activity of kinase F A/GSK-3a towards phosphorylation of brain -r could be stimulated approximately fourfold by heparin . The phosphorylation molar ratio was increased simultaneously up to 9 mol of phosphates/mol of T, resulting in a reduced mobility of T with an apparent molecular mass shift to -68 kDa in sodium dodecyl sulfate gels, which is very similar to that observed in Alzheimer-T . Tryptic digestion of 32 P-labelled T, followed by HPLC and twodimensional separation on TLC cellulose plates, revealed eight major phosphopeptides. Phosphoamino acid analysis together with sequential manual Edman degradation and protein sequence analysis further revealed that, in addition to Ser 235 and Ser 404 , heparin generated Thr 2' 2 , Thr 231 , Ser 262 , Ser 324 , and Ser 35s , the five extra phosphorylation sites in T. As Ser 235 , Ser 262 , Ser 324 , Ser 356 , and Ser 4o4 (particularly the site of Ser 262 ) have been identified as five of the most potent sites in T responsible for reducing microtubule binding possibly involved in neuronal degeneration, and Thr 231 , Ser 235 , Ser 262 , and Ser 4o4 are four of the most well documented sites abnormally phosphorylated in Alzheimer-T, the results provide initial evidence that protein kinase F A/GSK-3a after heparin potentiation may represent one of the most potent systems possibly involved in the abnormal phosphorylation of PHF - T in Alzheimer's disease brains . Key Words : Alzheimer's disease--r protein-Kinase F A/glycogen synthase kinase3a-Heparin -Abnormal sites . J. Neurochem. 63,1416-1425 (1994) . al ., 1988 ; Kondo et al ., 1988 ; Wischik et al ., 1988 ; Lee et al ., 1991) . As compared with normal brain T protein, the PHF-associated T appeared to be abnormally phosphorylated, which can cause an electrophoretic mobility shift in sodium dodecyl sulfate (SDS) gels (Greenberg and Davies, 1990; Ksiezak-Reding and Yen, 1991 ; Lee et al ., 1991) . The PHF-associated T was found to be abnormally phosphorylated on several 235 , 262 sites, including Thr"', Ser and Ser , as demonstrated by Ihara and co-workers using protein sequence and mass spectrometric analysis of T protein isolated from Alzheimer's disease brain (Hasegawa et al ., 1992) . On the other hand, Mandelkow and co-workers 235 262 identified Ser , Ser , and Ser 4° (particularly the site of Ser262) as three of the most potent sites in T responsible for reducing microtubule binding (Gustke et al ., 1992 ; Biernat et al ., 1993) . A reduction in microtubule binding would lead to destabilization of microtubules and, hence to a loss in axonal transport to cause neuronal degeneration (Kosik, 1990 ; Goedert et al ., 1991) . Several protein kinases, such as mitogen-activated protein kinase (MAP kinase) (Drewes et al ., 1992 ; Lichtenberg-Kraag et al ., 1992), T protein kinase I glycogen synthase kinase-3ß (GSK-3ß) (Ishiguro et al., 1992, 1993), T protein kinase II cyclin-dependent kinase-5 (cdk5) (Ishiguro et al ., 1991 ; Kobayashi et al ., 1993), proline-directed protein kinase (Vulliet et al ., 1992 ; Paudel et al ., 1993), and protein kinase FA/glycogen synthase kinase-3a (GSK-3a) (Hanger et al ., 1992 ; Mandelkow et al., 1992 ; Yang et al ., 1993b), have been reported to be capable of phosphorylating some Received January 14, 1994; revised manuscript received March 7, 1994 ; accepted March 8, 1994 . Address correspondence and reprint requests to Dr . S.-D. Yang at Institute of Biomedical Sciences, National Tsing Hua University, Hsinchu, Taiwan, R.O .C . Abbreviations used: cdk5, cyclin-dependent kinase-5 ; GSK-3, glycogen synthase kinase-3 ; MAP kinase, mitogen-activated protein kinase ; PAGE, polyacrylamide gel electrophoresis; PEG, polyethylene glycol ; PHF, paired helical filament; PMSF, phenylmethylsulfonyl fluoride ; SDS, sodium dodecyl sulfate. Neurofibrillary tangles are one of the major lesions that accumulate in Alzheimer's disease brain . The main components of neurofibrillary tangles are the paired helical filaments (PHFs), which consist mainly of the microtubule-associated protein T (Brion et al ., 1985 ; Kosik et al ., 1986 ; Yen et al ., 1987 ; Goedert et 1416 MODULATION OF ALZHEIMER-7 - KINASE of these sites . However, none of the reported T kinases is capable ofphosphorylating all of these sites (particularly the site of Ser 262) in PHF-T. The action mechanism for the abnormal phosphorylation of PHF-T, therefore, remains to be established. Protein kinase FA was identified originally as an activating factor of type-1 protein phosphatase from mammalian nonnervous tissues (Yang et al., 1980), which is identical to GSK-3a (Vandenheede et al., 1980; Hemmings and Cohen, 1983 ; Woodgett, 1991), but has been demonstrated subsequently to be a multisubstrate protein kinase existing most abundantly in the brain (Yang and Fong, 1985 ; Yu and Yang, 1993; for review, see Yang, 1991) . Protein kinase FA/GSK3a was identified further as a brain microtubule-associated T protein kinase that is able to phosphorylate Ser 23' and Ser er in T and reduces the electrophoretic mobility shift of T on SDS-polyacrylamide gel electrophoresis (PAGE), a unique property characteristic of PHF-T (Greenberg and Davies, 1990; Ksiezak-Reding and Yen, 1991; Lee et al., 1991), suggesting a possible involvement of kinase FA/GSK-3a in the abnormal phosphorylation of pathological PHF-T in Alzheimer's disease brain (Yang et al., 1991a, 1993b) . The phosphorylation of T by protein kinase FA/GSK-3a also decreases T's affinity for microtubule and actin filament binding, suggesting a possible involvement in the functional regulation of the neuronal cytoskeletal system (Yang et al., 1993a) . Hanger et al . (1992) also reported that kinase FA/GSK-3a reduced the mobility of T on SDS-PAGE and generated several PHF epitopes. They localized kinase FA/GSK-3a within granular structures in pyramidal cells, particularly the relative abundance in the CAI subicular areas, illustrating that kinase FA/GSK-3a may have a role in the pathogenesis of PHF, because these neurons are especially vulnerable to tangle formation in Alzheimer's disease . Mandelkow et al. (1992) also reported that kinase FA/ GSK-3a reduced the gel mobility shift of 7 -, generated several PHF epitopes, and associated with normal brain microtubules and with PHFs from Alzheimer brain, suggesting that kinase FA/GSK-3a may have a role in the induction of the Alzheimer-like state of T . However, as reported by Hanger et al. (1992) and Mandelkow et al. (1992), protein kinase FA/GSK-3a is present in roughly equivalent amounts in both normal and Alzheimer's disease brains, and there is no obvious difference in the immunolabelling of sections of control brain and Alzheimer brain . The role of kinase FA/GSK3a possibly involved in the abnormal phosphorylation of pathological PHF-,r in Alzheimer's disease brain, therefore, remains to be established . Here we report that heparin, a polyanion substance, can potentiate protein kinase FA/GSK-3a towards phosphorylation of bovine brain T on at least seven phosphorylation sites, including Thr2 ' 2, Thr23 ', Ser 23s, Ser 262, Ser 324, Ser 356 and Ser 404, numbered according to the longest human brain T isoform as described by Goedert et al. (1989), and causes a reduced mobility 141 7 of T with an apparent molecular mass shift to -68 kDa in SDS gels, which is very similar to that observed in PHF-T (Lee et al., 1991 ; Goedert et al., 1992), representing one of the most potent systems possibly involved in the abnormal phosphorylation of PHF-T. As protein kinase FA/GSK-3a is present in roughly equivalent amounts in normal and in Alzheimer's disease brain (Hanger et al., 1992; Mandelkow et al., 1992), raising the possibility that deregulation, but not ectopic expression, of kinase FA/GSK-3a may play an important role in Alzheimer disease pathogenesis, the polyanion compound-mediated generation of Alzheimer-like -r by kinase FA/GSK-3a reported here presents a new approach to this pathogenic mechanism . EXPERIMENTAL PROCEDURES Materials -32 [1' p]ATP was purchased from Amersham (Buckinghamshire, U.K.). ATP, ammonium bicarbonate, heparin (grade 1, from porcine intestinal mucosa), and L-1-tosylamide 2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin were from Sigma (St. Louis, MO, U.S.A.). EGTA, 2mercaptoethanol, phenylmethylsulfonyl fluoride (PMSF), methanol, benzamidinium chloride, trifluoroacetic acid, trichloroacetic acid, dithiothreitol, polyethylene glycol (PEG), and ferric chloride were from Merck (Darmstadt, F.R.G.). Phosphocellulose was from Whatman (Maidstone, U.K.). Ultrogel AcA-34 and chelating Sepharose CL 6B (fast flow) were from LKB (Uppsala, Sweden) . C,$ reverse-phase column (Cosmosil 5C,$-AR, 4.6 x 250 mm) was from Nacalai Tesque (Kyoto, Japan). Acetonitrile was from J. T. Baker (Phillipsburg, NJ, U.S.A.). Edman degradation reaction membrane (GEN 920033), phenylisothiocyanate, and coupling buffer (GEN 920020) were from Millipore (Bedford, MA, U.S .A.) . Purification and characterization of kinase FA/ GSK-3cr and T protein Protein kinase FA/GSK-3a was purified to homogeneity from porcine brain basically as described in previous reports (Yang, 1986; Yu and Yang, 1993) . The preparations of kinase FA phosphorylated myelin basic protein with a specific activity of - 1,600 nmol/min/mg and with a specific activity of 26,000 nmol/min/mg toward activation of inactive type1 protein phosphatase . When analyzed by SDS-PAGE and Coomassie Blue staining, the purified kinase FA gave a single major protein band at M, = 53,000 . Analysis of the radioactively autophosphorylated kinase FA on the autoradiogram also revealed a single major phosphorylated protein band at Mr = 53,000 . The enzyme preparations could also be specifically immunoblotted and immunoprecipitated by an anti-GSK-3a antibody produced from the peptide TETQTGQDWQAPDA, corresponding to the carboxyl terminal regions from amino acids 462-475 of the sequence of GSK3a (Woodgett, 1990) . The antibody could specifically immunoblot GSK-3a from crude brain extracts and could not cross-react with GSK-3ß, as described and demonstrated in a previous report (Yu and Yang, 1993) . The kinase FA preparations used in this report, therefore, belong to the category of GSK-3a according to the definition ofWoodgett and co-workers (Woodgett, 1990; Hughes et al., 1991). T protein was prepared from bovine brain following the J. Neurochem., Vol. 63, No. 4, 1994 141 8 S.-D. YANG ET AL. procedure of Cleveland et al . (1977) with some modifications . The purification began with homogenization of 400 g of brain in 2 volumes of solution A (40 mM Tris-HCl, pH 7 .4, 4 mM EDTA, 1 mM EGTA, 0 .1 % 2-mercaptoethanol, 1 mM PMSF, and 1 mM benzamidinium chloride) . The homogenate was centrifuged at 10,000 g at 4°C for 40 min . The crude brain extract was boiled at 100°C for 6 min, followed by centrifugation at 10,000 g at 4°C for 40 min . The resulting supernatant was applied directly to a phosphocellulose column (2 .6 X 20 cm) and washed with 5 column volumes of solution B (20 mM Tris-HCI, pH 7 .0, 1 mM EDTA, 0 .1% 2-mercaptoethanol, 0 .5 mM PMSF, and 0 .5 mM benzamidinium chloride). T protein was then eluted with solution B containing 0 .5 M NaCl . The crude T protein fractions identified by 10% SDS-PAGE were pooled and concentrated by dialysis against 30% PEG to a total volume of less than 5 ml, and then further purified by an AcA-34Ultrogel filtration column (2 .5 X 90 cm) previously equilibrated with solution B containing 0.2 M NaCl and eluted with the same solution . The pure T protein fractions on the AcA-34 column identified by 10% SDS-PAGE were collected, concentrated by dialysis against 30% PEG, and stored at -20°C for all the experiments mentioned throughout the text. The purified T revealed four major and two minor protein bands with apparent molecular masses ranging from approximately 55 to 62 kDa, basically as described by Cleveland et al . (1977) . Phosphorylation of T protein Standard phosphorylation of T protein was performed at 30°C in a 25-/cl reaction mixture containing 20 mM TrisHCI, pH 7 .0, 1 mM dithiothreitol, 0 .2 mM [,Y_32P]ATP (1 pmol = 1,000 cpm), 20 MM MgC1 2 , 360 hg/ml T protein, and 5 pg/ml kinase F A/GSK-3a in the presence or absence of 50 Fig/ml heparin . 32p incorporation into T protein was determined by spotting 20 /d of the reaction mixture onto Whatman P81 paper (1 X 2 cm), dropping into 75 mM phosphoric acid, and processing as described by Reimann et al . (1971) or by quantitation of the 32 P bands from SDSPAGE . Preparations of immobilized metal (Fe3 ') affinity chromatography column An immobilized metal affinity column was prepared according to Andersson and Porath (1986) . The chelating Sepharose CL 6B column (1 .5 X 5 cm) was washed with deionized water and equilibrated with FeC13 solution . The column was washed further with three column volumes of solution C (0 .1 M acetic acid/NaOH, pH 3 .1) and ready for use . Trypsin digestion and purification of tryptic digests of [3Z P]-r phosphorylated by kinase F A/GSK-3a For preparative phosphorylation of T protein, the reaction mixture, at a total volume of 0 .4 ml containing 0 .5 mg of pure T protein ; 0 .2 mM [y3 2 P]ATP (1 pmol ATP = 2,000 cpm), 20 MM MgC12 , 20 mM Tris-HCI, pH 7 .0, 0 .5 mM dithiothreitol, and 10 pg of pure kinase FA in the presence and absence of 50 pg/ml heparin, was incubated at 30° C for 3 h . The 100% trichloroacetic acid at a volume of 0 .1 ml was added next to stop the phosphorylation reaction . After centrifugation at 13,000 g at 25° C for 5 min, the pellets were washed twice with 0 .4 ml of 20% trichloroacetic acid and twice with 0 .4 ml of acetone . The washed pellets were resuspended in 0 .15 ml of 50 mM ammonium bicarbonate buffer, J. Neurochem., Vol. 63, No. 4, 1994 pH 8 .0, containing 6 wg of TPCK-treated trypsin and incubated at 37°C for 6 h . Another 6 Ng of trypsin was added to the reaction mixture every 6 h . This continued for 24 h . The tryptic digests of [32p]T were diluted with 3 ml of solution C and then applied to the Fe 3' affinity column prepared as described above . After absorption, the nonphosphopeptides were washed away by solution C, and the phosphopeptides of [ 32 P] r could be eluted with solution D (0 .1 M TrisHCI, pH 8 .5) . After concentration with a Speed-Vac concentrator (Savant), the phosphopeptides of the tryptic digests of [32P] -r resuspended in 0 .1 ml of deionized water, followed by syringe membrane filtration, were applied to a C, g reverse-phase column (0.8 X 10 cm) and eluted with a linear gradient of 0-35% acetonitrile in 0 .1% trifluoroacetic acid using a model 6200A HPLC System (Hitachi) . The flow rate was 0 .5% acetonitrile/min, and 0 .2-ml fractions were collected every 0 .25 min . The phosphopeptide peaks were localized by counting 0 .01-ml aliquots from each collected fraction in a liquid scintillation counter (model 1600TR, Packard) . Purity analysis of isolated phosphopeptides The purity of each isolated phosphopeptide was analyzed by the method used in two-dimensional peptide mapping as described by Boyle et al . (1991) . In brief, the phosphopeptide peaks resolved from HPLC as described above were collected separately and concentrated to dryness with a SpeedVac . The dried samples were resuspended in a minimal volume of solution E (formic acid/acetic acid/H 2 0, 50 :156 :1,794, pH 1 .9) and subjected to high-voltage electrophoresis in the first dimension on TLC cellulose plates (Merck) in the same buffer at 1 kV at 20°C for 40 min . Ascending chromatography in the second dimension was carried out in solution F (n-butanol/pyridine/acetic acid/H20, 15 :10 :3 :12) at 20°C for 6-8 h. After being air-dried, the TLC cellulose plates were exposed to x-ray films and autoradiographed to localize the 32 P-phosphopeptides. The 32P spots removed from TLC cellulose plates were extracted with 200 [1 of solution E at 30°C for 10 min . After centrifugation at 10,000 g for 10 min to spin down the fine cellulose powder, the extracted 32 p-phosphopeptides were dried and subjected to phosphoamino acid analysis, Edman degradation, and amino acid sequence analysis . Amino acid sequence analysis and determination of phosphorylation site sequences The amino acid sequencing analysis of the phosphopeptides isolated from tryptic digests of [32p] -r and eluted from TLC cellulose plates, as described above, was performed on a MilliGen/Bioresearch model 6600 sequencer . Radiosequencing of the phosphorylation site of the phosphopeptides isolated from tryptic digests of [32p] -r, as described above, was performed by sequential manual Edman degradation essentially according to Laursen (1966) and Laursen and Machleidt (1980) . In brief, the 32P-phosphopeptide fractions eluted from TLC cellulose plates and resuspended in 30% acetonitrile were incubated with reaction membrane at 56°C for 20 min and then washed with methanol and deionized water. The membrane was next incubated with 50 /1 of phenylisothiocyanate at 56 ° C for 5 min, followed by incubation with 50 11 of coupling buffer at 56°C for 15 min . The protected N-terminal amino acid was then cleaved from the membrane-linked peptides by 50 p1 of trifluoroacetic acid at 56°C for 10 min . At each reaction cycle, the trifluoroacetic acid extracts were subjected to 32p counting in a liquid scin- MODULATION OF ALZHEIMER--r KINASE FIG . 1 . Dose effect of heparin on the phosphorylation of T protein by kinase FA/GSK-3a. T protein (360 wg/ml) was phosphorylated by 5 wg/ml kinase FA/GSK-3a in the presence of various concentrations of heparin, as indicated, in a total volume of 25 pl at 30°C for 10 min. Detailed phosphorylation conditions and determination of 3ZP incorporation into T protein were as described in Experimental Procedures . tillation counter for determination of the phosphorylation site . Phosphoamino acid analysis Phosphoamino acid analysis was performed as described by Boyle et al. (1991) . The phosphopeptides isolated from tryptic digests of ["P]T and eluted from TLC cellulose plates, as described above, were hydrolyzed in 5 .7 M HCl under N 2 at 110 °C for 1 h . The hydrolysate was dried with a Speed-Vac concentrator, resuspended in solution E, and subjected to high-voltage electrophoresis in the first dimension on a cellulose-coated TLC plate in solution E at 1 .5 kV at 20°C for 20 min . The plate was air-dried and then subjected to the second dimensional high-voltage electrophoresis in solution G (acetic acid/pyridine/water, 10 :1 :189, pH 3 .5) at 1 .3 kV for 16 min, followed by autoradiography . The positions of the phosphoamino acids on the plates were localized by ninhydrin stain of the phosphorylated amino acid standards . Enzyme purifications and assays Phosphorylase b (Fischer and Krebs, 1958), phosphorylase b kinase (Cohen, 1973), and [3ZP]phosphorylase a (Krebs et al ., 1958) were purified and prepared from rabbit skeletal muscle . The inactive ATP-Mg-dependent type-1 protein phosphatase (Yang and Fong, 1985) and myelin basic protein (Yang et al ., 1987) were purified from porcine brain . The assay conditions for the measurement of kinase F A/GSK-3a as a myelin basic protein kinase and as an activating factor of inactive ATP-Mg-dependent type-1 protein phosphatase were as described in a previous report (Yang, 1986) . Analytic methods Protein concentrations were determined by the method of Lowry et al. (1951) using bovine serum albumin as the standard . SDS-PAGE was performed essentially according to the method of Laemmli (1970) . Autoradiography was carried out with a Fuji RX x-ray film using a Kodak X-Omatic cassette with intensifying screens . RESULTS The activity of protein kinase FA /GSK-3a towards phosphorylation of brain microtubule-associated pro- 141 9 tein T could be stimulated approximately fourfold by heparin in a concentration-dependent manner (Fig . 1). The 32 p-labelled T phosphorylated by kinase FA/GSK3a in the absence and presence of 50 /.cg/ml heparin at 30°C for 3 h was next subjected to 10% SDSPAGE, followed by autoradiography. In agreement with the previous reports (Yang et al., 1991a, 1993b; Hanger et al ., 1992 ; Mandelkow et al ., 1992), kinase FA/GSK-3a reduced the mobility of T on SDS-PAGE (Fig . 2A, lanes 1 and 2) . However, to our surprise, kinase FA/GSK-3a after heparin potentiation generated a reduced mobility of T with an apparent molecular mass shift to -68 kDa in SDS gels (Fig . 2A and B, lanes 2 and 3), which is very similar to that observed in PHF-T (Lee et al ., 1991 ; Goedert et al ., 1992). The further reduction in the gel mobility shift of T was not due to heparin itself, because heparin alone had no effect on T's mobility on SDS-PAGE (data not shown). By quantification of the 3Z P bands as shown in Fig . 2, we found that kinase F A/GSK-3a after heparin potentiation could phosphorylate T up to 9 mol of phosphates/mol of T. Furthermore, the 12 p-phosphates were incorporated rather equally into the different bands (Fig . 2), indicating that the in vitro phosphorylation described here was independent of the isoforms, as in Alzheimer's disease (Goedert et al ., 1992). Moreover, as normal human brain T contains 2-3 mol of phosphates/mol of T, whereas Alz- FIG. 2. SDS-PAGE and autoradiography of [ 3Z P]T phosphorylated by kinase FA/GSK-3a in the presence and absence of heparin. T protein (360 l,tg/ml) was 3ZP-phosphorylated with or without 5 IZg/ml kinase FA/GSK-3a in the absence and presence of 50 Mg/ml heparin in a total volume of 25 yI at 30°C for 3 h. The reaction mixture was quenched in Laemmli's sample buffer and analyzed by 10% SDS-PAGE, followed by autoradiography . Lane M, marker proteins, i.e., bovine serum albumin (68 kDa), glutamate dehydrogenase (55.6 kDa), and glyceraldehyde-3phosphate dehydrogenase (36 kDa) ; lanes 1, T protein alone; lanes 2, T protein plus kinase FA/GSK-3a; lanes 3, T protein plus kinase FA/GSK-3a and heparin. A: Coomassie Blue stain. B: Autoradiogram of the same gel . J. Neurochem ., Vol. 63, No. 4, 1994 1420 S . -D. YANG ET AL. FIG. 3 . C18 reverse-phase HPLC of the tryptic di- gests of [32p]T phosphorylated by kinase FA /GSK3a in the absence and presence of heparin. The tryptic digests of 0.5 mg of [32 P]T phosphorylated by 10 leg of kinase FA /GSK-3a in the absence (A) and presence (B) of 50 1cg/ml heparin in a total volume of 400 N,I at 30°C for 3 h were applied to a Fe" affinity column to remove nonphosphopeptides and then purified by C 18 reverse-phase HPLC . Detailed conditions were as described in Experimental Procedures . Fractions of 0.2 ml were collected every 0.25 min, and a 0.01-ml aliquot from each fraction was counted in a liquid scintillation counter to localize the phosphopeptide peaks. Fractions 33/34, 108/109, 128/129, 159-162, and 185 were taken as peaks I, II, III, IV, and V, respectively . heimer brain T contains 5-9 mol of phosphates/mol of T (Gong et al ., 1993), kinase FA/GSK-3a after heparin potentiation may generate an Alzheimer-like state of T. In an attempt to answer this question, the 32P-labelled T phosphorylated by kinase FA /GSK-3a in the presence of 50 wg/ml heparin up to 9 mol of phosphates/mol of T, was subjected subsequently to complete trypsin digestion, followed by C18 reversephase HPLC . The tryptic digests of [32p]T could be resolved into five major phosphopeptide peaks designated as peaks I, II, III, IV, and V on C, 8 reversephase HPLC when heparin and kinase FA/GSK-3a were used (Fig . 3B); in the absence of heparin, however, only peaks I and II could be phosphorylated significantly by kinase FA/GSK-3a (Fig . 3A) . Analysis of these phosphopeptide peaks phosphorylated by kinase FA/GSK-3a in heparin by high-voltage electrophoresis/TLC and autoradiography on TLC cellulose plates revealed that peak I contained three spots, peaks II, III, and V contained only one spot each, and peak IV contained two spots ; in the absence of heparin, peak I contained only two spots instead of the three spots generated by heparin, and peak II contained one spot (data not shown) . Amino acid sequence analysis of each phosphopeptide spot eluted from the TLC cellulose plates further revealed that the peak I fraction obtained from FA/GSK-3a in heparin contained three peptide fragments, with TPPKSPSAAK (la), TTPTPK (lb), and TPPKSPSAAK (Ic) as the amino acid sequences, whereas the peak I fraction obtained from FA/ GSK-3a in the absence of heparin contained only two peptide fragments, with TPPKSPSAAK (Ia) and TTPTPK (lb) as the amino acid sequences . It is noted that J. Neurochem., Vol. 63, No. 4, 1994 the two phosphopeptides (peaks la and Ic) appeared to have exactly the same sequence, but they could be differentiated from each other by the degree of phosphorylation (see Fig. 5) . On the other hand, peak IV contained two peptide fragments, with SRTPSLPTPPTR and CGSLGNIHHK as the amino acid sequences, and peaks II, III, and V were found to be homogeneous and contained only one peptide each, with SPVVSGDTSPR, IGSTENLK, and IGSLDNITHVPGGGNK as their respective amino acid sequences, as summarized in Fig . 5 . By taking together the results obtained from phosphoamino acid analysis (Fig . 4) and sequential manual Edman degradation (Fig . 5) of each phosphopeptide fraction eluted from the TLC cellulose plates as described above, we finally demonstrated TPPKS(p )PSAAK, TTPT(p) PK, T(p )PPKS( p)PSAAK, SPVVSGDTS (p )PR, IGS (p)TENLK, SRT(p )PSLPTPPTR, CGS (p )LGNIHHK, and IGS( p)LDNITHVPGGGNK as the phosphorylation site sequences in T phosphorylated by kinase FA/GSK-3a after heparin potentiation, as depicted in Fig . 5, whereas in the absence of heparin, FA/GSK-3a phosphorylates only TPPKS (p) PSAAK, TTPT(p)PK, and SPVVSGDTS (p)PR obtained from peaks I and II resolved from HPLC (Fig . 3A); these data are consistent with those of the previous report (Yang et al ., 1993b ; data not shown) . When mapping the human brain T sequence, we found that kinase FA/ GSK-3a after heparin potentiation phosphorylated T on Thr 212 , Thr 231 , Ser 23s Ser 262 Ser 324 Ser 3s6 , and Ser 404 , whereas in the absence of heparin, FA /GSK-3a phosphorylated only Ser 23s and Ser 4°4, according to the numbering of the longest T isoform isolated from human brain (Fig . 6 ; Goedert et al., 1989). Mnn»rATInw OF ALZHEIMER-T KINASE 1421 phosphorylating at least seven sites in T, including Thr 2 ` 2 , Thr 2", Ser 235 Ser 262, Ser 324, Ser 3s6 , and Ser 4°4 . Mandelkow and co-workers reported that among the 11 sites of T exhaustively phosphorylated by their unidentified T kinase(s) from brain extracts, Ser 235, Ser 262, and Ser 4°4 (in particular, the site of Ser 262) were found to be the most potent sites for most effectively reducing the microtubule binding that is possibly involved in the neuronal degeneration (Gustke et al ., 1992; Biernat et al., 1993) . The hyperphosphorylation of T may constitute one of the major causes of decreased microtubule binding, leading to destabilization of microtubules and, hence, to a loss in axonal transport to generate neuronal degeneration (Kosik, 1990; Goedert et al ., 1991) . Ihara and co-workers also reported Ser 4°4 as the site hyperphosphorylated in both PHF-T and fetal T as compared with adult T, which is only moderately phosphorylated on Ser 404 (Kanemaru et al., 1992; Watanabe et al., 1993). On the other hand, Ihara and co-workers, using protein sequence and mass spectrometric analysis of T from Alzheimer's disease brain, demonstrated Thr 231 , Ser 235 , and Ser 262 as three of the abnormal phosphorylation sites in PHF-T as compared with normal T (Hasegawa et al., 1992) . As summarized in Table 1, none of the reported T kinases, including MAP kinase (Drewes et al., 1992; Lichtenberg-Kraag et al ., 1992), T protein kinase I/GSK-3ß (Ishiguro et al ., 1992), T protein kinase II/cdk 5 (Ishiguro et al ., 1991 ; Kobayashi et al., 1993), prolinedirected brain kinase/cdk5 (Paudel et al ., 1993), and protein kinase F/GSK-3a (Mandelkow et al., 1992 ; FIG. 4. Phosphoamino acid analysis of the phosphopeptide peaks resolved from C, 8 reverse-phase HPLC of the tryptic digests of ]s2P]T protein phosphorylated by kinase FA/GSK-3a . The phosphopeptide peak fractions as indicated in Fig. 3 were first subjected to high-voltage electrophoresis/TLC, followed by autoradiography to localize the 32 P spots. The 32 P spots on the TLC cellulose plates were eluted and then subjected to phosphoamino acid analysis, as described in Experimental Procedures. The positions of the phosphorylated amino acid standards were visualized by ninhydrin staining . PS, phosphoserine; PT, phosphothreonine ; PY, phosphotyrosine; P,, inorganic phosphate. DISCUSSION In this report, we present further evidence that protein kinase F A/GSK-3a after heparin potentiation may generate an even more Alzheimer-like state of T . First, heparin can stimulate approximately fourfold the activity of kinase F/GSK-3a towards phosphorylation of T and increase the phosphorylation molar ratio up to 9 mol of phosphates/mol of T. Second, T phosphorylated by kinase F,,/GSK-3a and heparin appears to cause a reduced electrophoretic mobility of T with an apparent molecular mass shift to ^-68 kDa in SDS gels, which is very similar to that observed in PHF-T (Lee et al., 1991 ; Goedert et al., 1992) . Finally, kinase F/GSK-3a after heparin potentiation is capable of FIG. 5. Phosphorylation site sequences of the phosphopeptides resolved from C, 3 reverse-phase HPLC of the tryptic digests of [32p]T phosphorylated by kinase FA/GSK-3a in the presence of heparin. The 32 P spots eluted from TLC cellulose plates, as described in the legend to Fig. 4, were subjected to sequential manual Edman degradation and amino acid sequence analysis for the phosphorylation site sequence determination, as described in Experimental Procedures . The phosphorylated amino acids are indicated by asterisks in each peptide sequence . The experiments were performed in the presence of heparin . J. Neurochem., Vol. 63, No. 4, 1994 142 2 S. -D. YANG ET AL. r FIG. 6. Peptide mapping of the phosphorylated peptide fragments of 2P]-r by kinase F A/GSK-3a in the presence of heparin with the human brain r sequence . Amino acids were numbered according to the longest isoform of human T, as described by Goedert et al . (1989) . The kinase FA/GSK-3a-phosphorylated peptide fragments as depicted in Fig. 5 were mapped with the human T sequence and localized at residues 210-221, 231-240, 260-267, 322-331, 354-369, and 396-406, which are underlined . The phosphorylation sites, indicated by asterisks, were identified as Thr 2 ' 2, Thr231 , Ser 235 , Ser 262 , Ser 32° , Ser 356 and Ser°°^, respectively, in human T . The peak Ib sequence specifically exists in bovine brain T . The new consensus sequence -S-K-I(C)-G-S- in phosphopeptides of peaks III, IVb, and V are double-underlined. The experiments were performed in the presence of heparin. Yang et al., 1993b), were capable of phosphorylating all of these important sites, in particular, the site of Ser 262 . Protein kinase FA/GSK-3a after heparin potentiation turned out to be the only system currently available that could phosphorylate all of these important sites in T, as presented in this report . Taken together, the results provide initial evidence that protein kinase F/GSK-3a after heparin potentiation may represent one of the most potent systems possibly involved in the abnormal phosphorylation of PHF-T in Alzheimer's disease brain . Furthermore, as kinase F/GSK-3a appears to be present in roughly equal amounts in both normal and Alzheimer brain (Hanger et al., 1992; Mandelkow et al., 1992), this suggests that if the generation of PHF-7' in Alzheimer brain is indeed partly due to abnormal phosphorylation by kinase FA/GSK-3a as proposed, it may not be due to ectopic expression of kinase FA/GSK-3a, but due to the modulation of the kinase itself. The results presented here support this notion . It is possible that the abnormal phosphorylation of PHF-T by kinase FA/GSK-3a is due to the deregulation of kinase FA/GSK-3a via accumulation of a kinase J. Neurochem., Vol. 63, No. 4. 1994 stimulator, such as heparin and/or a heparin-like substance (a polyanion compound), as well as possibly a lower phosphatase activity, which can be potently inhibited by heparin (Yang et al., 1991b) in Alzheimer's disease brain (Gong et al ., 1993). This obviously presents a new approach for elucidating the pathogenic mechanism of Alzheimer's disease . In addition to Thr23 ', Ser 235 , Ser 262 , and Ser 404 as important sites possibly involved in the abnormal phosphorylation of PHF-T, both Tau-1 sites (Ser" and Ser e°2 ) (Kosik et al ., 1988; Biernat et al ., 1992 ; Goedert et al., 1993) and a T3-P site (Ser 396) (Lee et al., 1991 ; Bramblett et al., 1993) have also been identified as important sites abnormally phosphorylated in PHF-r. Mandelkow and co-workers found four sites phosphorylated by kinase FA/GSK-3a ; in particular, they demonstrated the phosphorylation of Tau-1, SM131, SMI33, and SM134 sites, corresponding to the phos phorylation of Ser' 99 , Ser e°2 , Ser 235 , Ser 396 , and Ser 404 (Mandelkow et al., 1992), in which recombinant T and specific antibodies were used to establish these phosphorylation sites . In this report, on the other hand, 1423 MODULATION OF ALZHEIMER-T KINASE TABLE 1. In vitro phosphorylation of T protein by various protein kinases Kinase Cat '/calmodulin kinase II Phosphorylation site" Ser T protein kinase II/cdk5 Ser2°2, Thr2°5 , Set 235, Ser404 Kinase C Ser324 ,r protein kinase I/GSK-3ß MAP kinase References Steiner et al ., 1990 Ishiguro et al., 1991 Kobayashi et al ., 1993 Ser' yy , Thr23 1 , Ser"', Set' 13 Set", Ser' yy, Ser22, Ser 235 , Ser396 , Ser°°°, Ser422 Kinase FA/GSK-3a Ser202 , Thr205 , Thr23 ', Ser235 Ser2 ", Ser324 , Ser'56, Set.409, Ser416 Ser' 15 , Set202, Thr205 , Thr23 ', Set 215, Ser3y6 , Ser104 Ser' yy G, Ser2°2 b, Ser235 , Ser"", Ser4°4 Kinase FA/GSK-3a + heparin Thr2 ' 2 , Thr23 ', Ser235 , Ser262, Ser324 , Ser356, SerAO4 p58`Y` °° A/p34°d" kinase from FM3A cells Cyclic AMP kinase Proline-directed brain kinase/cdk5 Correas et al., 1992 Ishiguro et al ., 1992 Drewes et al ., 1992 Lichtenberg- Kraag et al ., 1992 Vulliet et al ., 1992 Scott et al ., 1993 Paudel et al ., 1993 Mandelkow et al ., 1992 Yang et al ., 1993b Present study "The amino acid residue numbers are based on that of the longest human T isoform, as described by Goedert et al . (1989) . b Determined by antibody, not by peptide sequencing. we used purified brain T to determine them by direct sequencing. Whether the discrepancy on the phosphorylation of the Tau-1 and T3-P sites by FA/GSK-3a is due to nonspecific recognition of antibody (Poulter et al ., 1993) or due to the disadvantage of direct peptide sequencing obviously presents an intriguing problem that remains to be solved . In comparison with the similarities in T phosphorylation in fetal brain and in Alzheimer's disease brain, the sites of Thr 23 ', Ser 235 and Ser 4' appeared to be hyperphosphorylated in both fetal and Alzheimer's disease brains as compared with the normal adult brain T (Kanemaru et al., 1992; Hasegawa et al., 1993; Poulter et al., 1993 ; Watanabe et al., 1993) . The abnormal phosphorylation of T at Thr 23 ', Ser 235 , and Ser 4oa in Alzheimer disease, thus, recapitulates normal phosphorylation during development and can be regulated developmentally, suggesting a possible involvement of kinase FA/GSK-3a in the development of the brain . On the other hand, although the recognition determinants for kinase FA/GSK-3a have not been clearly established, two important features of the consensus sequence motif for kinase FA/GSK-3a have been proposed : (a) proline residues are usually in the vicinity of the phosphorylation sites, and kinase FA/GSK-3a is a Ser/Thr-Pro motif-directed protein kinase (Hemmings and Cohen, 1983 ; Vulliet et al., 1989; Ramakrishna et al., 1990; Woodgett, 1991) ; and (b) a prephosphorylated residue is essential for the subsequential action, and Ser-Arg-X-X-Ser may represent another mode of consensus sequence motif for kinase FA/GSK-3a (Fiol et al., 1987, 1990 ; Dent et al., 1989; Ramakrishna et al., 1990). In this study, we found that kinase FA/GSK-3a after heparin modification may recognize a new mode of consensus sequence motif, i.e., -S-K-I(C)-G-S- in the phosphopeptides of peaks III, IVb, and V, as presented in Fig . 5 and doubleunderlined in Fig . 6. Whether this new sequence motif can be recognized in other substrates is currently under investigation in this laboratory . Moreover, the new consensus sequence motifs were all located in the internal repeated sequences near the highly conserved carboxyl-terminal domain of T, which represents the tubulin-binding motifs (Himmler et al., 1989) . For instance, kinase FA/GSK-3a after heparin potentiation can phosphorylate Ser 262, Ser 324 , and Ser 356 , the three serine residues conserved in the repetitive tubulinbinding motifs (Fig. 6), which have been reported to be required for the in vivo colocalization of T protein to microtubules (Vulliet et al., 1992) . Phosphorylation of the three-repeat microtubule-binding domain may constitute an important mechanism for weakening the interactions of T with tubulin, thus destabilizing microtubules (Correas et al ., 1992). This further supports the notion that heparin may potentiate kinase FA/GSK-3a to cause hyperphosphorylation of T, with a subsequent destabilization of the microtubule cytoskeleton possibly involved in the neuronal degeneration in Alzheimer's disease (Kosik, 1990; Goedert et al., 1991) . Acknowledgment: This work was supported by grants NSC 81-0203-BO07-509 and NSC 82-0203-BO07-029 from the National Science Council of Taiwan, R.O.C . The work was also supported by grant CMRP-263 from Chang Gung Medical College and Memorial Hospitals of Taiwan, R.O .C. REFERENCES Andersson L . and Porath J . (1986) Isolation of phosphoproteins by immobilized metal (Fe") affinity chromatography. Anal. Biochem. 154, 250-254 . 1. Neurochem., Vol. 63, No. 4, 1994 142 4 S. -D. YANG ET AL. Biemat J ., Mandelkow E .-M., Schroter C ., Lichtenberg-Kraag B ., Steiner B ., Berling B ., Meyer H . E ., Mercken M., Vandermeeren A., Goedert M ., and Mandelkow E . (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region . EMBO J. 11, 1593-1597 . Biernat J ., Gustke N ., Drewes G ., Mandelkow E.-M ., and Mandelkow E . (1993) Phosphorylation of Ser ... strongly reduces binding of tau to microtubules : distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153-163 . Boyle W . J ., van der Geer P ., and Hunter T . (1991) Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates . Methods Enzymol. 201, 110-149 . Bramblett G. T ., Goedert M ., Jakes R., Merrick S . E., Trojanowski J . Q ., and Lee V . M .-Y . (1993) Abnormal tau phosphorylation at Ser" in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding . Neuron 10, 10891099 . Brion J.-P ., Couck A . M., Passareiro H., and Flament-Durand J . (1985) Neurofibrillary tangles of Alzheimer's disease : an immunohistochemical and immunoelectron study . J. Submicrosc . Cytol. 17, 89-96 . Cleveland D . W ., Hwo S .-Y ., and Kirschner M . W. (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin . J. Mol. Biol. 116, 207-225 . Cohen P. (1973) Subunit structure of rabbit skeletal muscle phosphorylase kinase, and molecular basis of its activation reaction. Eur. J. Biochem . 34, 1-14 . Correas I ., Diaz-Nido J., and Avila J . (1992) Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulinbinding domain . J. Biol. Chem. 267, 15721-15728 . Dent P ., Campbell D . G ., Hubbard M . J ., and Cohen P . (1989) Multisite phosphorylation of the glycogen-binding subunit of protein phosphatase-1 G by cyclic AMP-dependent protein kinase and glycogen synthase kinase-3 . FEBS Lett. 248, 67-72 . Drewes G ., Lichtenberg-Kraag B ., Doring F ., Mandelkow E .-M ., Biernat J ., Goris J ., Doree M ., and Mandelkow E . (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11, 2131-2138 . Fiol C . J ., Mahrenholz A . M ., Wang Y ., Roeske R . W ., and Roach P . J. (1987) Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3 . J. Biol. Chem . 262, 14042-14048 . Fiol C. J ., Wang A., Roeske R . W., and Roach P . J . (1990) Ordered multisite protein phosphorylation analysis of glycogen synthase kinase 3 action using model peptide substrates . J. Biol. Chem. 265, 6061-6065 . Fischer E. H . and Krebs E . G . (1958) Isolation and crystallization of rabbit-skeletal-muscle phosphorylase b . J. Biol . Chem . 231, 65-71 . Goedert M., Wischik C . M ., Crowther R. A ., Walker J . E., and Klug A. (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease : identification as the microtubule-associated protein tau . Proc. Natl. Acad. Sci. USA 85, 4051-4055 . Goedert M ., Spillantini M . G ., Jakes R ., Rutherford D., and Crowther R . A. (1989) Multiple isoforms of human microtubule-associated protein-tau-sequences and localization in neurofibrillary tangles of Alzheimer's disease . Neuron 3, 519-526 . Goedert M., Sisodia S . S ., and Price D . L . (1991) Neurofibrillary tangles and beta-amyloid deposits in Alzheimer's disease . Curr. Opin. Neurobiol. 1, 441-447 . Goedert M ., Spillantini M. G ., Cairns N . J ., and Crowther R . A . (1992) Tau protein of Alzheimer paired helical filaments : abnormal phosphorylation of all six brain isoforms . Neuron 8, 159168 . Goedert M ., Jakes R ., Crowther R. A ., Six J ., Lubke U ., Vandermeeren M ., Cras P ., Trojanowski J . Q ., and Lee V. M .-Y . (1993) The abnormal phosphorylation of tau protein at Ser-202 in AlzJ. Neurochem., Vol. 63, No. 4, 1994 heimer disease recapitulates phosphorylation during development . Proc. Nall . Acad. Sci . USA 90, 5066-5070 . Gong C .-X ., Singh T . J ., Grundke-Igbal I ., and Igbal K . (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain . J. Neurochem . 61, 921-927 . Greenberg S . G . and Davies P . (1990) A preparation of Alzheimer paired helical filaments that displays distinct T proteins by polyacrylamide gel electrophoresis . Proc. Natl. Acad. Sci . USA 87, 5827-5831 . Gustke N., Stainer B ., Mandelkow E.-M ., Biernat J ., Meyer H . E ., Goedert M ., and Mandelkow E . (1992) The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs . FEBS Lett. 307, 199205 . Hanger D . P ., Hughes K., Woodgett J . R ., Brion J.-P ., and Anderton B . H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase . Neurosci. Lett. 147, 58-62 . Hasegawa M., Morishima-Kawashima M ., Takio K ., Suzuki M., Titani K., and Ihara Y . (1992) Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain . J. Biol. Chem . 267, 17047-17054 . Hasegawa M., Watanabe A., Takio K., Suzuki M ., Arai T ., Titani K., and Ihara Y . (1993) Characterization of two distinct monoclonal antibodies to paired helical filaments : further evidence for fetal type phosphorylation of the 7" in paired helical filaments . J. Neurochem . 60, 2068-2077 . Hemmings B . A. and Cohen P . (1983) Glycogen synthase kinase-3 from rabbit skeletal muscle . Methods Enzymol. 99, 337-345 . Himmler A ., Kirschner M . W ., Martin D . W. Jr ., and Drechsel D . (1989) Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains . Mol. Cell . Biol. 9, 1381-1388 . Hughes K., Pulverer B . J., Theocharous P ., and Woodgett J . R. (1991) Baculovirus-mediated expression and characterization of rat glycogen synthase kinase-3,8, the mammalian homologue of the Drosophila melanogaster zeste-white 3sa8 homeotic gene product. Eur. J. Biochem. 203, 305-311 . Ishiguro K ., Omori A ., Sato K ., Tomizawa K ., Imahori K., and Uchida T . (1991) A serine/threonine proline kinase activity is included in the tau protein kinase fraction forming a paired helical filament epitope . Neurosci. Lett. 128, 195-198 . Ishiguro K ., Takamatsu M ., Tomizawa K., Omori A., Takahashi M ., Arioka M ., Uchida T ., and Imahori K. (1992) Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments . J. Biol. Chem. 267, 10897-10901 . Ishiguro K., Shiratsuchi A., Sato S ., Omon A ., Arioka M ., Kobayashi S ., Uchida T ., and Imahori K . (1993) Glycogen synthase kinase 3ß is identical to tau protein kinase I generating several epitopes of paired helical filaments . FEBS Lett. 325, 167-172 . Kanemaru K., Takio K., Miura R., Titani K ., and Ihara Y . (1992) Fetal-type phosphorylation of the T in paired helical filaments . J. Neurochem. 58, 1667-1675 . Kobayashi S ., Ishiguro K ., Omori A ., Takamatsu M ., Arioka M ., Imahori K., and Uchida T . (1993) A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule . FEBS Lett. 335, 171-175 . Kondo J ., Honda T ., Mori H ., Hamada Y ., Miura R., Ogawara M ., and Ihara Y . (1988) The carboxyl third of tau is tightly bound to paired helical filaments . Neuron 1, 827-834 . Kosik K. S . (1990) Tau protein and Alzheimer's disease. Curr. Opin. Cell Biol . 2, 101-104 . Kosik K. S ., Joachim C . L., and Selkoe D . J . (1986) Microtubuleassociated protein tau (T) is a major antigenic component of paired helical filaments in Alzheimer disease . Proc . Natl. Acad. Sci. USA 83, 4044-4048 . Kosik K . S ., Orecchio L . D ., Binder L ., Trojanowski J. Q ., Lee V. M .-Y ., and Lee G . (1988) Epitopes that span the tau molecules are shared with paired helical filaments . Neuron 1, 817825 . MODULATION OF ALZHEIMER-,F KINASE Krebs E . G ., Kent A. B ., and Fischer E . H. (1958) Molecular properties and transformation of glycogen phosphorylase in animal tissues. J. Biol. Chem. 231, 73-83 . Ksiezak-Reding H . and Yen S .-H . (1991) Structural stability of paired helical filaments requires microtubule-binding domains of tau : a model for self-association. Neuron 6, 717-728 . Laemmh U . K. (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4 . Nature 227, 680-685 . Laursen R . A . (1966) A solid-state Edman degradation. J. Am . Chem . Soc. 88, 5344-5346. Laursen R . A. and Machleidt W . (1980) Solid-phase methods in protein sequence analysis, in Methods of Biochemical Analysis, Vol. 26 (Glick D ., ed), pp . 201-284 . John Wiley and Sons, New York . Lee V . M .-Y ., Brain B . J ., Otvos L . Jr ., and Trajanowski J . Q . (1991) A68 : a major subunit of paired helical filaments and derivatized forms of normal tau . Science 251, 675-678 . Lichtenberg-Kraag B ., Mandelkow E.-M ., Biernat J ., Steiner B ., Schroter C., Gustke N ., Meyer H . E ., and Mandelkow E. (1992) Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc. Natl. Acad. Sci. USA 89, 5384-5388 . Lowry O . H ., Rosebrough N. J ., Farr A . L., and Randall R. J . (1951) Protein measurement with the Folin phenol reagent . J. Biol. Chem . 193, 265-275 . Mandelkow E.-M., Drewes G ., Biernat J ., Gustke N ., Van Lint J ., Vandenheede J . R ., and Mandelkow E . (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau . FEBS Lett. 314, 315-321 . Paudel H. K ., Lew J ., Ali Z ., and Wang J. H . (1993) Brain prolinedirected protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments . J. Biol . Chem . 268, 23512-23518 . Poulter L ., Barratt D ., Scott C . W ., and Caputo C . B . (1993) Locations and immunoreactivities of phosphorylation sites on bovine and porcine tau proteins and a PHF-tau fragment. J. Biol. Chem. 268, 9636-9644 . Ramakrishna S ., D'Angelo G ., and Benjamin W. B . (1990) Sequence of sites on ATP-citrate lyase and phosphatase inhibitor 2 phosphorylated by multifunctional protein kinase (a glycogen synthase kinase 3 like kinase) . Biochemistry 29, 7617-7624 . Reimann E . M ., Walsh D. A ., and Krebs E. G. (1971) Purification and properties of rabbit skeletal muscle adenosine 3',5'-monophosphate-dependent protein kinase . J. Biol. Chem. 246, 19861995 . Scott C . W., Spreen R . C ., Herman J . L ., Chow F . P., Davison M . D ., Young J ., and Caputo C . B . (1993) Phosphorylation of recombinant tau by CAMP-dependent protein kinase. Identifi cation of phosphorylation sites and effect on microtubule assembly . J. Biol. Chem. 268, 1166-1173 . Steiner B ., Mandelkow E.-M ., Biernat J ., Gustke N ., Meyer H. E ., Schmidt B ., Mieskes G ., Soling H . D ., Drechsel D ., Kirschner M . W ., Goedert M., and Mandelkow E . (1990) Phosphorylation of microtubule-associated protein tau: identification of the site for Ca"-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles . EMBO J. 9, 3539-3544. Vandenheede J . R., Yang S .-D ., Goris J ., and Merlevede W . (1980) ATP - Mg-dependent protein phosphatase from rabbit muscle. Purification of the activating factor and its regulation as a bifunctional protein also displaying synthase kinase activity . J. Biol. Chem. 255, 11768-11774 . 142 5 Vulliet P . R ., Hall F . L ., Mitchell J . P ., and Hardie D . G . (1989) Identification of a novel proline-directed serine/threonine protein kinase in rat pheochromocytoma. J. Biol. Chem . 264, 16292-16298 . Vulliet R., Halloran S . M., Braun R . K., Smith A . J ., and Lee G . (1992) Proline-directed phosphorylation of human tau protein . J. Biol. Chem . 267, 22570-22574 . Watanabe A ., Hasegawa M ., Suzuki M ., Takio K., Morishima-Kawashima M ., Titani K ., Arai T ., Kosik K . S ., and Ihara Y . (1993) In vivo phosphorylation sites in fetal and adult rat tau . J. Biol. Chem. 268, 25712-25717 . Wischik C . M ., Novak M ., Thogersen H ., Edwards P. C ., Runswick M . J ., Jakes R., Walker J . E ., Milstein C ., Roth M ., and Klug A . (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease . Proc. Nod. Acad. Sci . USA 85, 4506-4510 . Woodgett J . R . (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A . EMBO J. 9, 2431-2438 . Woodgett J. R . (1991) A common denominator linking glycogen metabolism, nuclear oncogenes and development . Trends Biochem . Sci. 16, 177-181 . Yang S .-D . (1986) Identification of the ATP - Mg-dependent protein phosphatase activator F as a myelin basic protein kinase in the brain. J. Biol . Chem . 261, 11786-11791 . Yang S .-D . (1991) Characteristics and regulation of the ATP-Mgdependent protein phosphatase activating factor (protein kinase FA) . Adv . Prot . Phosphatases 6, 133-157 . Yang S .-D. and Fong Y .-L . (1985) Identification and characterization of an ATP-Mg-dependent protein phosphatase from pig brain . J. Biol. Chem. 260, 13464-13470 . Yang S .-D ., Vandenheede J . R ., Goris J., and Merlevede W . (1980) ATP-Mg-dependent phosphorylase phosphatase from rabbit muscle. J. Biol. Chem . 255, 11759-11767 . Yang S .-D ., Liu J.-S ., Fong Y.-L., Yu J .-S ., and Tzen T.-C . (1987) Endogenous basic protein phosphatases in the brain myelin . J. Neurochem . 48, 160-166 . Yang S .-D., Yu J .-S ., and Lai Y.-G . (1991a) Identification and characterization of the ATP - Mg-dependent protein phosphatase activator (FA) as a microtubule protein kinase in the brain . J. Prot. Chem . 10, 171-181 . Yang S .-D ., Song J .-S., Hsieh Y .-T ., and Liu H .-W . (1991b) Selective modulation of the two antagonistic activities of protein kinase F,, (the activator of ATP-Mg-dependent protein phosphatase) . Biochem . Biophys. Res . Commun. 176, 145-149. Yang S .-D ., Chan W .-H ., and Liu H .-W . (1993a) Cyclic modulation of cytoskeleton assembly-disassembly by the ATP-Mg-dependent protein phosphatase activator (kinase FA) . Biochem . Biophys. Res . Commun . 193, 1202-1210 . Yang S .-D ., Song J .-S ., Yu J .-S ., and Shiah S .-G. (1993b) Protein kinase FA /GSK-3 phosphorylates T on Ser 235-Pro and Set"Pro that are abnormally phosphorylated in Alzheimer's disease brain . J. Neurochem. 61, 1742-1747 . Yen S .-H ., Dickson D . W ., Crowe A ., Butler M., and Shelanski M . L. (1987) Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtu bule associated proteins tau and map2 . Am . J. Pathol . 126, 8191 . Yu J .-S . and Yang S .-D . (1993) Immunological study on tissue and subcellular distributions of protein kinase FA (an activating factor of ATP-Mg-dependent protein phosphatase) . A simpli fied and efficient procedure for high quantity purification from brain. J. Prot. Chem. 12, 665-674. J. Neurochem., Vol. 63, No. 4, 1994